← Open Payments lookup

DANIELLE WALDRON: Open Payments

NPI 1851724223 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$893 in 30 payments from 11 companies in 2025. Trend: 2023 $633 · 2024 $1,024 · 2025 $893

Food & beverage: $893
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$141
ABBVIE INC.3$139
Axsome Therapeutics, Inc.1$125
Otsuka America Pharmaceutical, Inc.3$124
Supernus Pharmaceuticals, Inc.5$109
E.R. Squibb & Sons, L.L.C.1$81
Bausch Health US, LLC4$72
Collegium Pharmaceutical, Inc.2$38
Lundbeck LLC1$29
Janssen Pharmaceuticals, Inc1$17

Products named: CAPLYTA, VRAYLAR, Auvelity, Qelbree, COBENFY, ABILIFY ASIMTUFII, APLENZIN, REXULTI.

Industry payments across WA — which companies pay providers there.